Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
135
NMPA:135
Drug Approvals
Cefprozil for Suspension
- Product Name
- 头孢丙烯干混悬剂
- Approval Number
- 国药准字H20254445
- Approval Date
- Jun 3, 2025
NMPA
Ranitidine Hydrochloride Capsules
- Product Name
- 盐酸雷尼替丁胶囊
- Approval Number
- 国药准字H44021173
- Approval Date
- May 14, 2024
NMPA
Sulfadiazine Silver Cream
- Product Name
- 磺胺嘧啶银乳膏
- Approval Number
- 国药准字H44020614
- Approval Date
- May 14, 2024
NMPA
Naphazoline Hydrochloride Nasal Drops
- Product Name
- 盐酸萘甲唑啉滴鼻液
- Approval Number
- 国药准字H20198006
- Approval Date
- Apr 9, 2024
NMPA
Sulfacetamide Sodium Eye Drops
- Product Name
- 磺胺醋酰钠滴眼液
- Approval Number
- 国药准字H20198004
- Approval Date
- Mar 15, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 14
- Next
Clinical Trials
No trials found
News
No news found